PROSTATE CANCER BONE METASTASES: ROLE OF ADRENOMEDULLIN
前列腺癌骨转移:肾上腺髓质素的作用
基本信息
- 批准号:7212216
- 负责人:
- 金额:$ 33.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-01 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelApoptosisBiological AssayBone MatrixBone ResorptionBone remodelingBreastCalvariaCancer ModelCell physiologyCellsCharacteristicsClinicalComplexDataDevelopmentGoalsGrowthGrowth FactorIn VitroInnate Bone RemodelingInterventionMalignant neoplasm of lungMalignant neoplasm of prostateMetastatic Neoplasm to the BoneMusNeoplasm MetastasisOsteoblastsOsteoclastsOsteogenesisPatientsPhysiologicalProcessProductionProtein OverexpressionProteinsRoleSamplingSignal PathwaySiteSolid NeoplasmStatistically SignificantTestingTherapeutic InterventionTreatment EfficacyTumor Angiogenesisadrenomedullinangiogenesisautocrinebasebisphosphonatebonebone cellcancer cellcell motilityin vivoinhibitor/antagonistloss of functionneoplastic cellparacrinepolypeptiderelease factorresearch studyresponsesoft tissuetumortumor growth
项目摘要
DESCRIPTION (provided by applicant): Adrenomedullin [AM] is a polypeptide secreted by prostate cancers and potent stimulator of bone formation and osteoblast proliferation. It also proangiogenic and antiapoptotic for tumor cells, thus having autocrine and paracrine roles in bone metastases. We propose that AM from prostate cancer cells contributes to a vicious cycle of bone metastasis by: 1) paracrine stimulation of osteoblast proliferation and tumor angiogenesis, and 2) autocrine effects on the tumor cells. We propose that AM production by prostate cancer is increased by growth factors in bone, which is a major storage site for immobilized growth factors: these are released by osteoclastic bone resorption and are also synthesized by osteoblasts. Both processes are increased by metastatic tumor cells. Bone-derived factors stimulate tumor cells to grow, as well as to produce more factors that stimulate osteoblasts and bone resorption, causing a vicious cycle characteristic of bone metastases. The release of factors from bone into the microenvironment can be decreased by bisphosphonate inhibitors of bone resorption. Our preliminary data support a role for AM in bone metastases:
1) AM is a potent stimulator of new bone formation in a mouse calvarial assay; 2) loss of function of AM decreased bone metastases in a lung cancer model; and 3) prostate cancer cells overexpressing AM had accelerated bone metastases and showed osteoblastic responses. We propose four hypotheses:
a) Adrenomedullin increases prostate cancer bone metastases
b) Tumor AM is increased in bone versus soft tissue metastases
c) AM has autocrine growth and paracrine angiogenic effects on prostate cancer cells
d) Tumor-secreted AM stimulates bone by increasing osteoblast proliferation
We propose to test these hypotheses with Three Specific Aims:
Aim 1: Determine the effects of tumor adrenomedullin on bone metastases
Aim 2: Determine changes in AM expression caused by the bone microenvironment
Aim 3: Determine paracrine effects of AM on bone cell function & angiogenesis
Our goal is to test the physiological importance of AM secreted by cancer cells in vivo and to validate it as a target for therapeutic intervention aimed at breaking the vicious cycle of prostate cancer metastases to bone.
描述(由申请人提供):肾上腺髓质素[AM]是前列腺癌分泌的一种多肽,是骨形成和成骨细胞增殖的有效刺激剂。它还具有促血管生成和抗肿瘤细胞凋亡的作用,因此在骨转移中具有自分泌和旁分泌作用。我们认为,来自前列腺癌细胞的AM通过以下方式参与骨转移的恶性循环:1)旁分泌刺激成骨细胞增殖和肿瘤血管生成,以及2)对肿瘤细胞的自分泌作用。我们建议,AM生产前列腺癌增加骨,这是一个主要的存储站点固定化生长因子的生长因子:这些是由骨细胞骨吸收释放,也合成成骨细胞的生长因子。转移性肿瘤细胞增加了这两个过程。骨源性因子刺激肿瘤细胞生长,并产生更多的刺激成骨细胞和骨吸收的因子,导致恶性循环的骨转移的特征。骨吸收的双磷酸盐抑制剂可以减少因子从骨骼释放到微环境中。我们的初步数据支持AM在骨转移中的作用:
1)在小鼠颅骨试验中,AM是新骨形成的有效刺激物; 2)AM功能丧失减少肺癌模型中的骨转移; 3)过表达AM的前列腺癌细胞加速骨转移并显示成骨细胞反应。我们提出四个假设:
a)肾上腺髓质素增加前列腺癌骨转移
B)骨转移瘤与软组织转移瘤相比,肿瘤AM增加
c)AM对前列腺癌细胞具有自分泌生长和旁分泌血管生成作用
d)肿瘤分泌的AM通过增加成骨细胞增殖来刺激骨
我们建议用三个具体目标来检验这些假设:
目的1:确定肿瘤肾上腺髓质素在骨转移中的作用
目的2:确定骨微环境引起的AM表达变化
目的3:确定AM对骨细胞功能和血管生成的旁分泌作用
我们的目标是在体内测试癌细胞分泌的AM的生理重要性,并验证其作为治疗干预的靶点,旨在打破前列腺癌骨转移的恶性循环。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THERESA A GUISE其他文献
THERESA A GUISE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THERESA A GUISE', 18)}}的其他基金
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
(PQ
- 批准号:
9486907 - 财政年份:2016
- 资助金额:
$ 33.98万 - 项目类别:
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
(PQ
- 批准号:
9935202 - 财政年份:2016
- 资助金额:
$ 33.98万 - 项目类别:
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.
(PQ
- 批准号:
10328409 - 财政年份:2016
- 资助金额:
$ 33.98万 - 项目类别:
PROSTATE CANCER BONE METASTASES: ROLE OF ADRENOMEDULLIN
前列腺癌骨转移:肾上腺髓质素的作用
- 批准号:
6918192 - 财政年份:2005
- 资助金额:
$ 33.98万 - 项目类别:
ENDOTHELIN-1 IN NORMAL AND PATHOLOGICAL BONE REMODELING
内皮素-1 在正常和病理性骨重建中的作用
- 批准号:
7336763 - 财政年份:2005
- 资助金额:
$ 33.98万 - 项目类别:
PROSTATE CANCER BONE METASTASES: ROLE OF ADRENOMEDULLIN
前列腺癌骨转移:肾上腺髓质素的作用
- 批准号:
7032983 - 财政年份:2005
- 资助金额:
$ 33.98万 - 项目类别:
ENDOTHELIN-1 IN NORMAL AND PATHOLOGICAL BONE REMODELING
内皮素-1 在正常和病理性骨重建中的作用
- 批准号:
7005690 - 财政年份:2005
- 资助金额:
$ 33.98万 - 项目类别:
PROSTATE CANCER BONE METASTASES: ROLE OF ADRENOMEDULLIN
前列腺癌骨转移:肾上腺髓质素的作用
- 批准号:
7391126 - 财政年份:2005
- 资助金额:
$ 33.98万 - 项目类别:
ENDOTHELIN-1 IN NORMAL AND PATHOLOGICAL BONE REMODELING
内皮素-1 在正常和病理性骨重建中的作用
- 批准号:
6868304 - 财政年份:2005
- 资助金额:
$ 33.98万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 33.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 33.98万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 33.98万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




